🎈 Up Big Today: Find today's biggest gainers with our free screenerTry Stock Screener

Brain Biotechnology Research (BNNn)

Xetra
Currency in EUR
4.2300
-0.0700(-1.63%)
Closed
BNNn Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
4.16004.3600
52 wk Range
1.41504.4000
Key Statistics
Edit
Bid/Ask
4.17 / 4.28
Prev. Close
4.3
Open
4.36
Day's Range
4.16-4.36
52 wk Range
1.415-4.4
Volume
17.59K
Average Volume (3m)
33.8K
1-Year Change
19.15%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BNNn Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
6.3000
Upside
+48.9362%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory
Show more

Brain Company Profile

BRAIN Biotech AG engages in the research and development of Bio-based products and solutions in Germany, the United States, France, the Netherlands, and the United Kingdom. It operates in three segments: BioProducts, BioScience, and BioIncubator. The company offers enzymes and biocatalysts to produce food and beverages, wound care preparations or lubricants, and production of starch and bioethanol; and microorganisms as the functional biomass for optimized industrial production processes, recycling of the greenhouse gas CO2 as an industrial raw material, and urban and green mining for extraction of precious and rare earth metals. It also provides biocatalysts and other bioactive natural compounds to produce foodstuffs and animal feed, cosmetics, and medical products, as well as for industrial applications in chemical companies, waste and hazardous materials disposal, and energy and raw materials production. The company was formerly known as B.R.A.I.N. Biotechnology Research and Information Network AG and changed its name to BRAIN Biotech AG in April 2021. BRAIN Biotech AG was founded in 1993 and is headquartered in Zwingenberg, Germany.

Compare BNNn to Peers and Sector

Metrics to compare
BNNn
Peers
Sector
Relationship
P/E Ratio
−10.5x13.4x−0.1x
PEG Ratio
0.310.030.00
Price/Book
5.7x0.9x1.6x
Price / LTM Sales
1.6x0.7x1.3x
Upside (Analyst Target)
30.6%18.4%28.4%
Fair Value Upside
Unlock20.9%1.8%Unlock

Analysts' Recommendations

4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 6.3000

(+48.94% Upside)

People Also Watch

7.46
TNIE
+3.04%
49.050
SMHNn
-0.91%
7.70
IBU
+1.05%
48.65
D6HG
+5.76%

FAQ

What Is the Brain (BNNn) Stock Price Today?

The Brain stock price today is 4.23

What Stock Exchange Does Brain Trade On?

Brain is listed and trades on the Xetra stock exchange.

What Is the Stock Symbol for Brain?

The stock symbol for Brain is "BNNn."

What Is the Brain Market Cap?

As of today, Brain market cap is 92.41M.

What is Brain Earnings Per Share?

The Brain EPS is -0.402.

What Is the Next Brain Earnings Date?

Brain will release its next earnings report on 15 Jan 2025.

From a Technical Analysis Perspective, Is BNNn a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.